Danish Dude, This document created by NWBO and Flaskworks to help us understand the difference between EDEN and every other bioreactor on the market. You're right; it's essential reading for anyone who truly wants to understand how DCVax works. Manufacturing is key! Don't just read the powerpoint notes, though that helps. Read the PDF:
Here are a few items I thought were worth repeating from the text though I'm just starting to read:
? Multi-Patient Throughput: Crucially, the instrument is designed to run multiple patient cartridges simultaneously within a single unit. This parallel processing capability allows one technician to oversee the production of several personalized doses at once, a fundamental requirement for scaling up to meet market demand.
The patent talked about this verson of Eden have more than one bioreactor. I had wondered if they meant that it cultured more than one patient's cells, and it appears it does. The patent mentions as many as 5, though the unit in the picture appeared to have two.
? GMP and Data Integrity: The system is built from the ground up for GMP compliance, automatically generating comprehensive, unalterable electronic batch records that meet the stringent 21 CFR Part 11 requirements for FDA and MHRA review.
Looks like GMP compliance will be much easier!
? Real-Time Process Control: A suite of inline sensors constantly monitors critical parameters like pH, temperature, and optical density. This data feeds into a closed-loop software system that can make real-time adjustments, ensuring every batch meets specification and providing alerts for any deviation.
Remember the huge cost of quality control that Linda talked about? This system does all that while culturing the cells.